Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Long-Term Functional Outcome of Surgical Treatment for Thoracic Outlet Syndrome.

Peek J, Vos CG, Ünlü Ç, Schreve MA, van de Mortel RHW, de Vries JPM.

Diagnostics (Basel). 2018 Jan 12;8(1). pii: E7. doi: 10.3390/diagnostics8010007.

2.

Long-term outcome and quality of life after ruptured abdominal aortic aneurysm repair.

Yildirim H, van Lammeren GW, Ünlü Ç, van Dongen EP, van de Mortel RH, de Vries JP.

Vascular. 2018 Jun;26(3):231-238. doi: 10.1177/1708538117727360. Epub 2017 Aug 22.

PMID:
28828934
3.

Median nerve neuropraxia by a large false brachial artery aneurysm.

Lijftogt N, Cancrinus E, Hoogervorst EL, van de Mortel RH, de Vries JP.

Vascular. 2014 Oct;22(5):378-80. doi: 10.1177/1708538113516321. Epub 2013 Dec 17.

PMID:
24347134
4.

Early computed tomographic angiography after endovascular aneurysm repair: worthwhile or worthless?

Waasdorp E, van Herwaarden JA, van de Mortel RH, Moll FL, de Vries JP.

Vascular. 2008 Sep-Oct;16(5):253-7.

PMID:
19238865
5.

Risk factors for surgical-site infection following common femoral artery endarterectomy.

Derksen WJ, Verhoeven BA, van de Mortel RH, Moll FL, de Vries JP.

Vasc Endovascular Surg. 2009 Feb-Mar;43(1):69-75. doi: 10.1177/1538574408323502. Epub 2008 Sep 30.

PMID:
18829586
6.

Collective experience with hybrid procedures for suprarenal and thoracoabdominal aneurysms.

van de Mortel RH, Vahl AC, Balm R, Buth J, Hamming JF, Schurink GW, de Vries JP.

Vascular. 2008 May-Jun;16(3):140-6.

PMID:
18674462
7.

Functional results after through-knee and above-knee amputations: does more length mean better outcome?

Met R, Janssen LI, Wille J, Langezaal AE, van de Mortel RW, van de Pavoordt ED, de Vries JP.

Vasc Endovascular Surg. 2008 Oct-Nov;42(5):456-61. doi: 10.1177/1538574408316914. Epub 2008 May 5.

PMID:
18458050
8.

Rupture of a popliteal artery aneurysm 10 years after surgical repair.

van Santvoort HC, de Vries JP, van de Mortel R, Wille J, van de Pavoordt ED.

Vascular. 2006 Jul-Aug;14(4):227-30.

PMID:
17026915
9.

Long-term results of percutaneous transluminal angioplasty for symptomatic iliac in-stent stenosis.

Kropman RH, Bemelman M, Vos JA, van den Berg JC, van de Pavoordt HD, van de Mortel RH, Moll FL, de Vries JP.

Eur J Vasc Endovasc Surg. 2006 Dec;32(6):634-8. Epub 2006 Jul 26.

10.

Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States.

Zelmanowicz Ade M, Schiffman M, Herrero R, Goldstein AM, Sherman ME, Burk RD, Gravitt P, Viscidi R, Schwartz P, Barnes W, Mortel R, Silverberg SG, Buckland J, Hildesheim A.

Int J Cancer. 2005 Sep 10;116(4):599-605.

11.

Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci.

Carrington M, Wang S, Martin MP, Gao X, Schiffman M, Cheng J, Herrero R, Rodriguez AC, Kurman R, Mortel R, Schwartz P, Glass A, Hildesheim A.

J Exp Med. 2005 Apr 4;201(7):1069-75.

12.

Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.

Lacey JV Jr, Potischman N, Madigan MP, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lurain JR, Fillmore CM, Sherman ME, Brinton LA.

Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):607-12.

13.

Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix.

Burk RD, Terai M, Gravitt PE, Brinton LA, Kurman RJ, Barnes WA, Greenberg MD, Hadjimichael OC, Fu L, McGowan L, Mortel R, Schwartz PE, Hildesheim A.

Cancer Res. 2003 Nov 1;63(21):7215-20.

14.

Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix.

Lacey JV Jr, Swanson CA, Brinton LA, Altekruse SF, Barnes WA, Gravitt PE, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Kurman RJ, Hildesheim A.

Cancer. 2003 Aug 15;98(4):814-21.

15.

Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States.

Altekruse SF, Lacey JV Jr, Brinton LA, Gravitt PE, Silverberg SG, Barnes WA Jr, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Hildesheim A.

Am J Obstet Gynecol. 2003 Mar;188(3):657-63.

PMID:
12634637
16.

Nanoscopic Pt colloids in the "embryonic state".

Angermund K, Bühl M, Dinjus E, Endruschat U, Gassner F, Haubold HG, Hormes J, Köhl G, Mauschick FT, Modrow H, Mörtel R, Mynott R, Tesche B, Vad T, Waldöfner N, Bönnemann H.

Angew Chem Int Ed Engl. 2002 Nov 4;41(21):4041-4. No abstract available.

PMID:
12412075
17.

Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies.

Wang SS, Hildesheim A, Gao X, Schiffman M, Herrero R, Bratti MC, Sherman ME, Barnes WA, Greenberg MD, McGowan L, Mortel R, Schwartz PE, Zaino RJ, Glass AG, Burk RD, Karacki P, Carrington M.

J Infect Dis. 2002 Sep 1;186(5):598-605. Epub 2002 Jul 29.

PMID:
12195346
18.

Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.

Wang SS, Hildesheim A, Gao X, Schiffman M, Herrero R, Bratti MC, Sherman ME, Barnes WA, Greenberg MD, McGowan L, Mortel R, Schwartz PE, Zaino RJ, Glass AG, Burk RD, Karacki P, Carrington M.

Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):419-20. No abstract available.

19.

Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma.

Dong SM, Pai SI, Rha SH, Hildesheim A, Kurman RJ, Schwartz PE, Mortel R, McGowan L, Greenberg MD, Barnes WA, Sidransky D.

Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):3-6.

20.

Hormonal treatment of endometrial cancer: past, present and future.

Podczaski E, Mortel R.

Best Pract Res Clin Obstet Gynaecol. 2001 Jun;15(3):469-89. Review.

PMID:
11476566
21.

Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States).

Lacey JV Jr, Frisch M, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Zaino RJ, Hildesheim A.

Cancer Causes Control. 2001 Feb;12(2):153-61.

PMID:
11246844
22.

Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.

Gravitt PE, Lacey JV Jr, Brinton LA, Barnes WA, Kornegay JR, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Zaino R, Hildesheim A.

Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):95-100.

23.

Tubal sterilization and risk of cancer of the endometrium.

Lacey JV Jr, Brinton LA, Mortel R, Berman ML, Wilbanks GD, Twiggs LB, Barrett RJ.

Gynecol Oncol. 2000 Dec;79(3):482-4.

PMID:
11104624
24.
25.

Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix.

Lacey JV Jr, Brinton LA, Barnes WA, Gravitt PE, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Kurman RJ, Hildesheim A.

Gynecol Oncol. 2000 Apr;77(1):149-54.

PMID:
10739704
26.

Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.

Lacey JV Jr, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Silverberg SG, Hildesheim A.

Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1079-85.

27.

p53 polymorphism and risk of cervical cancer.

Hildesheim A, Schiffman M, Brinton LA, Fraumeni JF Jr, Herrero R, Bratti MC, Schwartz P, Mortel R, Barnes W, Greenberg M, McGowan L, Scott DR, Martin M, Herrera JE, Carrington M.

Nature. 1998 Dec 10;396(6711):531-2. No abstract available.

PMID:
9859989
28.

Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors.

Zelmanowicz A, Hildesheim A, Sherman ME, Sturgeon SR, Kurman RJ, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD, Brinton LA.

Gynecol Oncol. 1998 Jun;69(3):253-7.

PMID:
9648597
29.

Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors.

Sturgeon SR, Sherman ME, Kurman RJ, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Brinton LA.

Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):231-5.

30.

Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas.

Sherman ME, Sturgeon S, Brinton LA, Potischman N, Kurman RJ, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD.

Mod Pathol. 1997 Oct;10(10):963-8.

PMID:
9346174
31.

Intrauterine device use and endometrial cancer risk.

Sturgeon SR, Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lurain JR.

Int J Epidemiol. 1997 Jun;26(3):496-500.

PMID:
9222773
32.

Gestational trophoblastic disease presenting as a large metastasis to the finger.

Hetzel DJ, Olt GJ, Sorosky JI, Mortel R, Singapuri K, Podczaski ES.

Gynecol Oncol. 1996 Oct;63(1):123-6.

PMID:
8898181
33.

Case-control study of endogenous steroid hormones and endometrial cancer.

Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, Swanson CA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Persky V, Lurain JR.

J Natl Cancer Inst. 1996 Aug 21;88(16):1127-35.

PMID:
8757192
34.

Staging and recurrence of disease in squamous cell carcinoma of the vulva.

Ndubisi B, Kaminski PF, Olt G, Sorosky J, Singapuri K, Hackett T, Hetzel D, Zaino R, Mortel R, Podczaski E.

Gynecol Oncol. 1995 Oct;59(1):34-7.

PMID:
7557612
35.

Surgical predictors of para-aortic metastases in early-stage cervical carcinoma.

Hackett TE, Olt G, Sorosky JI, Podczaski E, Harrison TA, Mortel R.

Gynecol Oncol. 1995 Oct;59(1):15-9.

PMID:
7557602
36.

Endometrial cancer risk in relation to serum lipids and lipoprotein levels.

Swanson CA, Potischman N, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD, Hoover RN, Brinton LA.

Cancer Epidemiol Biomarkers Prev. 1994 Oct-Nov;3(7):575-81.

37.

Endometrial carcinoma and its precursors.

Sorosky JI, Olt GJ, Mortel R.

Curr Ther Endocrinol Metab. 1994;5:562-6. No abstract available.

PMID:
7704793
38.

Moderate alcohol consumption and the risk of endometrial cancer.

Swanson CA, Wilbanks GD, Twiggs LB, Mortel R, Berman ML, Barrett RJ, Brinton LA.

Epidemiology. 1993 Nov;4(6):530-6.

PMID:
8268282
39.

Sex steroid receptors in endometrial carcinoma.

Satyaswaroop PG, Mortel R.

Gynecol Oncol. 1993 Sep;50(3):278-80. No abstract available.

PMID:
8406186
40.

Past and present physical activity and endometrial cancer risk.

Sturgeon SR, Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD.

Br J Cancer. 1993 Sep;68(3):584-9.

41.

Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial.

Stehman FB, Bundy BN, Thomas G, Keys HM, d'Ablaing G 3rd, Fowler WC Jr, Mortel R, Creasman WT.

J Clin Oncol. 1993 Aug;11(8):1523-8.

PMID:
8336190
42.

Relation of endometrial cancer risk to past and contemporary body size and body fat distribution.

Swanson CA, Potischman N, Wilbanks GD, Twiggs LB, Mortel R, Berman ML, Barrett RJ, Baumgartner RN, Brinton LA.

Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):321-7.

43.

Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study)

Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, Mortel R.

Gynecol Oncol. 1993 Jun;49(3):279-83.

PMID:
8314530
44.

Oral contraceptives and endometrial cancer: do other risk factors modify the association?

Stanford JL, Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Hoover RN.

Int J Cancer. 1993 May 8;54(2):243-8.

PMID:
8486426
45.

Dietary associations in a case-control study of endometrial cancer.

Potischman N, Swanson CA, Brinton LA, McAdams M, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD, Hoover RN.

Cancer Causes Control. 1993 May;4(3):239-50.

PMID:
8318640
46.

Cigarette smoking and the risk of endometrial cancer.

Brinton LA, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD.

Am J Epidemiol. 1993 Feb 1;137(3):281-91.

PMID:
8452136
47.

Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study.

Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lannom L, Hoover RN.

Am J Obstet Gynecol. 1992 Nov;167(5):1317-25.

PMID:
1442985
49.

Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study).

Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, Mortel R.

Am J Obstet Gynecol. 1991 Apr;164(4):997-1003; discussion 1003-4.

PMID:
2014852
50.

Hormonal treatment of endometrial carcinoma: an overview and new development in biology.

Satyaswaroop PG, Mortel R.

J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):997-1001. Review.

PMID:
2285611

Supplemental Content

Loading ...
Support Center